Acanthosis nigricans and insulin resistance

Acanthosis nigricans has been closely linked to insulin resistance (IR) and may act as a marker for early onset of type 2 diabetes

This study of 30 patients investigated the correlation between physical findings of acanthosis nigricans (AN) and IR.
Patients at a private dermatology clinic with a BMI ≥25 and signs of AN were invited to participate. Digital images of the neck and axilla were taken, and a history including familial history of type 2 diabetes. Fasting serum glucose and insulin values were obtained.

The images were assessed and posterolateral neck pigmentation and/or texture and axillary pigmentation and/or texture recorded.

The homeostasis model assessment of IR (HOMA-IR) was used. IR is considered to be present in non-diabetic patients if HOMA-IR is >1.775.

The results indicated that HOMA-IR was greater than 1.775 for 25 of 30 patients (83%). Posterolateral neck texture had the highest sensitivity (96%) and OR (17.3) for IR compared with neck pigment or axillary texture and pigment. The authors propose the term ‘insulin neck’ to describe this potential marker for IR and suggest all patients with raised BMI should be examined for it.

Payne KS, Rader RK, Lastra G et al. JAMA Dermatol 2013; 149: 875-7

Read these next

Common benign epidermal lesions in the elderly

Common benign epidermal lesions in the elderly

Cryotherapy is a mainstay of treatment in many of these...

Acanthosis nigricans and systemic disease

This skin condition may be an indicator of underlying...

Expert opinion: Cutaneous problems in insulin therapy

Skin problems are common in patients who inject insulin....

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases